Edwards Lifesciences Corp. produces the Carpentier-Edwards
The PERIMOUNT Magna mitral valve was launched in Europe in September 2005. It incorporates features of the Carpentier-Edwards PERIMOUNT mitral valve, which has demonstrated 16 years of durability, including the treatment of the bovine pericardial tissue leaflets with the Carpentier-Edwards ThermaFix process.
September 2008
Oct. 23, 2024 – The Society for Vascular Surgery (SVS) is launching a three-year patient education campaign, Highway to ...
October 23, 2024 
June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...
June 13, 2024 
June 3, 2024 — Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported ...
June 03, 2024 
May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive ...
May 16, 2024 
April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular ...
April 30, 2024 
April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...
April 23, 2024 
March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...
March 20, 2024 
February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...
February 26, 2024 
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first ...
February 23, 2024 
January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...
January 29, 2024